Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07011147 · ClinicalTrials.gov registry record · NA
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
A NA study of Diabetes Mellitus, Type 2 and Diabetes, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 2
- Study locations
NCT07011147 is a NA study of Diabetes Mellitus, Type 2 and Diabetes that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 240 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT07011147, a NA study of Diabetes Mellitus, Type 2 and Diabetes, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this randomized controlled trial is to compare the efficacy and safety of the iLet Bionic Pancreas (BP) System in adults with insulin-treated diabetes (type 1 diabetes or type 2 diabetes) compared to standard of care when ordered by primary care providers. The main question it aims to answer is: Can the iLet BP by deployed in primary care settings to adults with insulin-treated diabetes (type 1 diabetes or type 2 diabetes)? Researchers will compare 13-weeks of iLet BP use to routine care to see if iLet BP use has a greater reduction in HbA1c compared to13-weeks of routine care. Participants will: Use the iLet BP for 13-weeks or continue their routine care Be trained to use the study devices or continue their routine care Complete a virtual screening visit, mid-period follow up calls and a final visit Complete baseline CGM collection Complete surveys and fingerstick a1c blood tests Routine care participants will have the option to complete an observational extension phase where they will wear the iLet BP for 13-weeks
Conditions Studied
Interventions
- OTHER Routine Care
- DEVICE Bionic Pancreas
Study Locations (2)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2029-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07011147
The ClinicalTrials.gov registry entry for NCT07011147 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (95% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Routine Care is the first listed.
NCT07011147 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07011147 about?
NCT07011147 is a clinical study titled "Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery". The goal of this randomized controlled trial is to compare the efficacy and safety of the iLet Bionic Pancreas (BP) System in adults with insulin-treated diabetes (type 1 diabetes or type 2 diabetes) compared to standard of care when ordered by primary care providers. The main question it aims to an...
What is the current status of trial NCT07011147?
This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2026-02-01. Estimated completion is 2029-04-01.
What conditions does trial NCT07011147 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Diabetes, Type 2 Diabetes, Diabetes Mellitus, Type 1 Diabetes (T1D).
What interventions are being tested in trial NCT07011147?
The interventions under investigation include: Routine Care (OTHER), Bionic Pancreas (DEVICE).
Who is sponsoring clinical trial NCT07011147?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07011147 being conducted?
This trial has 2 study locations across Colorado, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.